Tau distribution in probable Cerebral Amyloid Angiopathy
暂无分享,去创建一个
D. Na | S. Seo | Hanna Cho | Hee Jin Kim | C. Lyoo | Y. Kim | Jin San Lee | Y. Jang | Juyoun | Lee
[1] C. DeCarli,et al. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage , 2015, Alzheimer's & Dementia.
[2] Keith A. Johnson,et al. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.
[3] Leonard Petrucelli,et al. Understanding Biomarkers of Neurodegeneration: Novel approaches to detecting tau pathology , 2015, Nature Medicine.
[4] D. Werring,et al. Cortical superficial siderosis , 2015, Neurology.
[5] M. Yamada. Cerebral Amyloid Angiopathy: Emerging Concepts , 2015, Journal of stroke.
[6] Kazuhiko Yanai,et al. Tau PET Imaging in Alzheimer’s Disease , 2014, Current Neurology and Neuroscience Reports.
[7] C. Rowe,et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[8] H. Kolb,et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.
[9] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[10] Michel Goedert,et al. Tau pathology and neurodegeneration , 2013, The Lancet Neurology.
[11] J. Trojanowski,et al. Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy , 2011, The Journal of Neuroscience.
[12] Keith A. Johnson,et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy , 2010, Annals of neurology.
[13] Sang Won Seo,et al. Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients , 2010, Journal of Korean medical science.
[14] C. Rowe,et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage , 2010, Neurology.
[15] S. Greenberg,et al. Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy , 2009, Annals of neurology.
[16] S. Love,et al. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.
[17] S. Greenberg,et al. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.
[18] S. Greenberg. Cerebral Amyloid Angiopathy , 2000 .
[19] H. Vinters. Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.
[20] A. Delacourte. Tau pathology and neurodegeneration: an obvious but misunderstood link. , 2008, Journal of Alzheimer's disease : JAD.
[21] A. Verma,et al. Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy , 2008 .
[22] S. Love. Contribution of cerebral amyloid angiopathy to Alzheimer's disease. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[23] B T Hyman,et al. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. , 2000, Acta neuropathologica.
[24] R. Campbell,et al. Clinicopathologic studies of primary cerebral amyloid angiopathy. , 1979, Mayo Clinic proceedings.